TSX runs higher on rate cut expectations
Gary Owens, the President and CEO of Mesa Laboratories Inc. (NASDAQ:MLAB), a $687 million market cap company with strong revenue growth of 11.7%, reported a significant transaction involving the company’s common stock. According to InvestingPro analysis, the company currently trades above its Fair Value. On March 19, 2025, Owens sold 21,000 shares at an average price of $123.91 per share, totaling approximately $2.6 million. This sale was executed under a Rule 10b5-1 trading plan, which Owens adopted on September 12, 2024.
In addition to the sale, Owens also acquired 21,000 shares through the exercise of stock options at a price of $122.98 per share, amounting to a total value of approximately $2.58 million. Following these transactions, Owens holds 43,337 shares of Mesa Laboratories directly.
In other recent news, Mesa Laboratories reported a 13.2% increase in organic growth for the quarter, marking its strongest performance since 2022. The company exceeded expectations for both revenue and earnings, showcasing robust financial health. Analysts at KeyBanc Capital Markets have maintained a Sector Weight rating for Mesa Labs, noting the company’s strategic positioning for future consolidation. Mesa Labs is preparing its balance sheet for potential acquisitions, with $30 million in purchasing capacity and favorable EV/EBITDA ratios, indicating readiness to accelerate its consolidation strategy.
Additionally, Mesa Laboratories announced a regular quarterly dividend of $0.16 per share, scheduled for payment on March 17, 2025, to shareholders on record as of February 28, 2025. This move underscores the company’s commitment to returning value to its shareholders. The company has also issued forward-looking statements predicting future revenues and growth while acknowledging potential risks and uncertainties. Investors are encouraged to review Mesa Labs’ official financial documents for a more comprehensive understanding of these projections and associated risks.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.